Comparative transcriptomics reveals specific responding genes associated with atherosclerosis in rabbit and mouse models

PLoS One. 2018 Aug 1;13(8):e0201618. doi: 10.1371/journal.pone.0201618. eCollection 2018.

Abstract

Mouse and rabbit are frequently employed species for atherosclerosis research. With respect to modeling human atherosclerosis, it has been observed that variations in phenotype under commonly used atherogenic conditions are partial or no congruence between two species. However, genome-wide molecular variations are still lacking. To understand the differences between rabbit and mouse in developing atherosclerosis, here from aspect of orthologs, we compared the genome-wide expression profiles of two species under the same atherosclerosis driven factors: high-fat diet or LDLR deficiency. Our results illuminated that: 1) LDLR-deficiency induced different gene expression changes in rabbit and mouse. WHHL rabbit had more significantly differential expressed genes and the most of genes were down-regulated. 2) Some genes and functions were commonly dysregulated in high-fat fed rabbit and mouse models, such as lipid metabolism and inflammation process. However, high-fat intake in rabbit produced more differentially expressed genes and more serious functional effects. 3) Specific differential expression genes were revealed for rabbit and mouse related with high-fat intake. In the aspect of lipoprotein metabolism, APOA4 and APOB was the major responding gene in rabbit and mice, respectively. The expression change of APOA4 and APOB in human atherosclerosis was more similar to rabbit, and therefore rabbit might be a better animal model for investigating human lipoprotein metabolism related diseases. In conclusion, our comparative transcriptome analysis revealed species-specific expression regulation that could partially explain the different phenotypes between rabbit and mouse, which was helpful for model selection to study atherosclerosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins A / genetics*
  • Apolipoproteins B / genetics*
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics*
  • Diet, High-Fat / adverse effects*
  • Disease Models, Animal
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Humans
  • Lipid Metabolism
  • Mice
  • Rabbits
  • Receptors, LDL / deficiency*
  • Sequence Analysis, RNA
  • Species Specificity

Substances

  • Apolipoproteins A
  • Apolipoproteins B
  • Receptors, LDL
  • apolipoprotein A-IV

Grants and funding

This work was supported by (1) the National Key R&D Program of China (grand No. 2017YFC0907505, 2017YFC0908405, 2017YFC1201200), http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm; (2) Chinese Academy of Sciences (grand No. ZDBS-SSW-DQC-02), http://english.cas.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.